WS #10230
AbbVie reportedly acquiring Apogee for ~$11B, targeting Dupixent rival.
AbbVie-Apogee acquisition rumor
AbbVie reportedly acquiring Apogee for ~$11B, targeting Dupixent rival.
AbbVie reportedly acquiring Apogee for ~$11B, targeting Dupixent rival.
AbbVie reportedly acquiring Apogee for ~$11B, targeting Dupixent rival.